4Unterberger U,Voigtlander T,Budka H.Pathogenesis of prion diseases.Acta Neuropathologica,2005,109:32-48.
5Van Everbroeck B,Boons PC.Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.Clin Neurol Neurosurgery,online 12 January 2005.
6Collinge J.Molecular neurology of prion disease.J Neurol Neurosurg Psychiatry,2005,76:906-925.
7Gerard L,Géraldine M.The population distribution of the Met allele at the PRNP129 polymorphism (a high risk factor for Creutzfeldt-Jakob disease) in various regions of France and in West Europe.Infect Genet Evol,2005,5:141-144.
8Notari S,Capellari S,Giese A,et al.Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD.J Biol Chem,2004,279:16797-16804.
9Tanaka M,Chien P,Naber N,et al.Conformational variations in an infectious protein determine prion strain differences.Nature,2004,428:323-328.
1Brown DR, Wong BS, Hafiz F, et al. Normal prion protein has an activity like that of superoxide dismutase[J]. Biochem, 1999, 344: 1-5.
2Shake Y, Rosenmann H, Hijazi N, et al. Copper binding to the PrP isoforms: a putative marker of their conformaiton and function[J]. J Virol, 2001, 75(17): 7872-7874.
3Philippe Derreumaux. Evidence that the 127-164 region of prion proteins has two equi-energetic conformations with (beta) or (alpha) features[J]. Biophysical Journal, 2001, 8: 11657-11662.
4Riek R, Hornemann S, Wider G, et al. NMR structure of the mouse prion protein domain PrP(121-231)[J]. Nature, 1996, 382: 180-182.
5Zahn R, Liu T, Luhrs R, et al. NMR solution structure of the human prion protein[J]. Proc Natl Acad Sci, 2000, 97: 145-150.
6Nandi PK. Bunuasual proterty of prion protein unfolding in neutral salt solution[J]. Biochemistry, 2002(41): 11017-11024.
7Roberto C, Pedro P, Elena Q, et al. Molecular distinction between pathogenic and infectious properties of the prion protein[J]. J Virol, 2003(77): 7611-7622.
8Gabus C, Auxilien S, Pechoux P. The prion has DNA properties similar to retroviral nucleocapsid protein[J]. J Mol Biol, 2001, 307 (4): 1011-1021.
9Vorberg I, Priola SA. Molecular basis of scrapie strain glycoform variation[J]. J Bio Chem, 2002, 277: 36775-36781.
10Belay ED. Transmissible spongiform encephalopathies in human[J]. Annu Rev Microbio, 1999, 53: 283-314.
7Safar JG, Geschwind MD, Deering C, et al. Diagnosis of human prion disease [J]. Proc Natl Acad Sci U S A, 2005,102 (9) :3501- 3506.
8Schlenska GK, Walter GF. Temporal evolution of electroencephalographic abnormalities in Creutzfeldt-Jakob disease [J]. J Neurol, 1989,236(8) :456-460.
9Puoti G, Bizzi A, Forloni G, et al. Sporadic human prion diseases: molecular insights and diagnosis [J]. Lancet Neurol, 2012, 11(7):618-628.
10Gadgil NM, Chaudhari CS, Gohil SD, et al. Creutzfeldt Jacob disease: an autopsy case report in tertiary care hospital [J]. Indian J Pathol Microbiol, 2012,55(1):97-99.
